Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

Linduarte Varela Morais, Aldair Sousa Paiva, PhDMD, Valéria SF Sales, PhD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2019) 134 (Supplement_1): 4990.

https://doi.org/10.1182/blood-2019-123802

Published: 2019

Journal Articles

In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia

Armelle Goubard, PhD, Martine Humbert, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group

Blood (2019) 134 (Supplement_1): 5142.

https://doi.org/10.1182/blood-2019-127143

Published: 2019

Journal Articles

AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes

Armelle Goubard, PhD, Martine Humbert, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group

Blood (2019) 134 (Supplement_1): 5154.

https://doi.org/10.1182/blood-2019-127021

Published: 2019

Journal Articles

Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939

Martine Humbert, PhD, Armelle Goubard, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group

Blood (2019) 134 (Supplement_1): 2075.

https://doi.org/10.1182/blood-2019-122540

Published: 2019

Journal Articles

Effect of Dietary Counseling on Chemotherapy Induced Weight Gain in Patients with Hematologic and Oncologic Malignancies

Damien Hansra, MD, Norman-Tiner Catherine, Diaz Catherine, RN, Randolph Caroline, RD, Hugo Granada, MD

Blood (2017) 130 (Supplement 1): 5664.

https://doi.org/10.1182/blood.V130.Suppl_1.5664.5664

Published: 2017

Journal Articles

Incidence and Risk Factors for IVIG-Mediated Hemolysis

Jacob Pendergrast, MDFRCPC, Beth Binnington, MSc, Tik Nga Tong, Jeannie Callum, MD, Christine Margaret Cserti-Gazdewich, BSc, MD FRCPC, Wendy Lau, MBBS,FRCPC, Lani Lieberman, MD, Yulia Lin, MD, Katerina Pavenski, MD BSc, FRCPC, Nadine Shehata, MDFRCPC,MSc, Rae Yeung, MD PhD FRCP, Donald R. Branch, PhD

Blood (2017) 130 (Supplement 1): 2398.

https://doi.org/10.1182/blood.V130.Suppl_1.2398.2398

Published: 2017

Journal Articles

Effects of Rituximab and Dexamethasone on Regulatory and Pro-Inflammatory B-Cell Subsets in Patients with Primary Immune Thrombocytopenia

Sif Gudbrandsdottir, MD PhD, Marie Brimnes, PhD, Tania Kollgaard, PhD, Hans Carl Hasselbalch, MD Professor, DMSc, Claus Henrik Nielsen, MD Professor, DMSc

Blood (2016) 128 (22): 1378.

https://doi.org/10.1182/blood.V128.22.1378.1378

Published: 2016

Journal Articles

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Masaki Hayakawa, MD, Seiji Kato, PhD, Taei Matsui, PhD, Kazuya Sakai, MD, Yumi Yoshii, MD, Hideo Yagi, MD.PhD, Yoshihiro Fujimura, MD, PhD, Masanori Matsumoto, MD.PhD

Blood (2016) 128 (22): 3773.

https://doi.org/10.1182/blood.V128.22.3773.3773

Published: 2016

Journal Articles

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Glaivy Batsuli, MD, Wallace Hunter Baldwin, BS, John F Healey, BS, Ernest T Parker, BS, Courtney Cox, MSc, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2016) 128 (22): 3762.

https://doi.org/10.1182/blood.V128.22.3762.3762

Published: 2016

Journal Articles

ABO Identical and Washed Transfusions Are Candidate Strategies to Reduce Early Mortality in Acute Promyelocytic Leukemia (APL)

Majed A. Refaai, MD, Kelly F Henrichs, BS, MT(ASCP), Joanna M. Heal, MBBS, MRCP, Amy E Schmidt, MD PhD, Jason H. Mendler, MD PhD, Scott A. Kirkley, MD, Christopher Aquina, MD, Debra Masel, BS, MT(ASCP) SBB, Jane Liesveld, MD, Neil Blumberg, MD

Blood (2016) 128 (22): 4011.

https://doi.org/10.1182/blood.V128.22.4011.4011

Published: 2016

Journal Articles

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Glaivy Batsuli, MD, John Healey, BS, Ernest Parker, BS, Wallace Hunter Baldwin, BS, Courtney Cox, MSc, Brenda Nguyen, BS, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2015) 126 (23): 1066.

https://doi.org/10.1182/blood.V126.23.1066.1066

Published: 2015

Journal Articles

Stable Blood Group Chimerism in Recipients of ABO Incompatible Allogeneic Stem Cell Transplantation

Ami Glik, MD, Lilach Bonstein, PhD, Nardeen Atwah, BSc, Eti Ganon-Elazar, PhD, Israel Henig, MD, Nuhad Haddad, MD, Riva Fineman, MD, Jacob M. Rowe, MD, Tsila Zuckerman, MD

Blood (2014) 124 (21): 1553.

https://doi.org/10.1182/blood.V124.21.1553.1553

Published: 2014

Journal Articles

Pharmacokinetic Evaluation of a Newly Introduced Von Willebrand Factor Concentrate At Two London Haemophilia Centres

Oliver Hegener, PhD, Natasha M Wiles, BSc, MBBS, MRCP, MRCPath, Anne Wareing, Bella Madan, MD, MRCP, FRCPath, Steve K Austin, Dr

Blood (2012) 120 (21): 3384.

https://doi.org/10.1182/blood.V120.21.3384.3384

Published: 2012

Journal Articles

Specific N- and O-Linked Carbohydrate Structures Mediate Von Willebrand Factor Interaction with Galectins -1 and -3

Orla Rawley, Jamie O'Sullivan, Gudmundur Bergsson, PhD, Alain Chan, PhD, Rachel Therese McGrath, Maartje van den Biggelaar, Jan Voorberg, Vince Jenkins, PhD, James S O'Donnell, MD, PhD

Blood (2011) 118 (21): 2234.

https://doi.org/10.1182/blood.V118.21.2234.2234

Published: 2011

Journal Articles

Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation

Shannon L. Meeks, John F. Healey, Ernest T. Parker, Rachel T. Barrow, Pete Lollar

Blood (2007) 110 (13): 4234–4242.

https://doi.org/10.1182/blood-2007-06-096842

Published: 2007

Journal Articles

Blood Group O and ABO Non-Identical Platelet Transfusions Are Associated with Increased Red Cell Utilization in Non-Trauma Surgical Patients.

Neil Blumberg, MD, Lawrence B. Fialkow, DO, Kelly Gettings, MT (ASCP), Andrea Zucchiatti, MD, Joanna M. Heal, MBBS, Paul E. Bankey, MD

Blood (2007) 110 (11): 4012.

https://doi.org/10.1182/blood.V110.11.4012.4012

Published: 2007

Journal Articles

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar, MD

Blood (2007) 110 (11): 784.

https://doi.org/10.1182/blood.V110.11.784.784

Published: 2007

Journal Articles

Anti-Von Willebrand Factor Antibody Is Responsible for Lower Levels of Plasma vWF in Blood Group O Individuals.

Letian Dai, PhD, Shawn Cotton, MSc, Alistair Macartney, MSc, Geoffrey Savidge, MD, Anwar Alhaq, PhD

Blood (2004) 104 (11): 254.

https://doi.org/10.1182/blood.V104.11.254.254

Published: 2004

NARROW

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia

AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes

Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939

Effect of Dietary Counseling on Chemotherapy Induced Weight Gain in Patients with Hematologic and Oncologic Malignancies

Incidence and Risk Factors for IVIG-Mediated Hemolysis

Effects of Rituximab and Dexamethasone on Regulatory and Pro-Inflammatory B-Cell Subsets in Patients with Primary Immune Thrombocytopenia

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

ABO Identical and Washed Transfusions Are Candidate Strategies to Reduce Early Mortality in Acute Promyelocytic Leukemia (APL)

Anti-C1 Domain Antibodies Are Pathogenic in a Murine Tail Snip Model Despite Low Inhibitor Titers

Stable Blood Group Chimerism in Recipients of ABO Incompatible Allogeneic Stem Cell Transplantation

Pharmacokinetic Evaluation of a Newly Introduced Von Willebrand Factor Concentrate At Two London Haemophilia Centres

Specific N- and O-Linked Carbohydrate Structures Mediate Von Willebrand Factor Interaction with Galectins -1 and -3

Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation

Blood Group O and ABO Non-Identical Platelet Transfusions Are Associated with Increased Red Cell Utilization in Non-Trauma Surgical Patients.

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Anti-Von Willebrand Factor Antibody Is Responsible for Lower Levels of Plasma vWF in Blood Group O Individuals.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only